Illumina releases DRAGEN v4.0 secondary analysis platform
July 27, 2022 -- Illumina has released Illumina Dynamic Read Analysis for Genomics (DRAGEN) v4.0 as its most accurate and comprehensive secondary analysis platform. The new features allow laboratories to expand capabilities in analysis in oncology, pharmacogenomics, single-cell sequencing, and population genomics. Read More
NGS detects mutation that causes spinal muscular atrophy
July 27, 2022 -- Gustavo Barcelos Barra and colleagues at Sabin Medicina Diagnostica in Brasilia, Brazil, are developing a next-generation sequencing (NGS) panel that detects a mutation in a small spot on the SMN1 gene which causes spinal muscular atrophy. Read More
Spanish researchers unlock the mystery of multidrug resistance
July 25, 2022 -- A team from the Spanish National Cancer Research Centre has determined that mutations that inactivate the function of a particular gene, FBXW7, reduce the sensitivity to the vast majority of drugs and result in multidrug resistance, according to a study published July 21 in EMBO Molecular Medicine. Read More
Companies announce new products ahead of AACC 2022
July 22, 2022 -- Several companies have announced the launch of laboratory diagnostic products in advance of AACC 2022. Read More
Scientists publish whole-genome sequences of 150k individuals from U.K. Biobank
July 20, 2022 -- In a paper published today in the journal Nature, scientists from Amgen subsidiary Decode Genetics with collaborators from Denmark report they have determined the whole-genome sequences of 150,119 individuals from the U.K. Biobank and identified more than 600 million sequence variants. Read More
Study examines effects of mutations in KRAS, which could enable earlier cancer detection
July 20, 2022 -- University of California, Santa Cruz researchers have discovered a key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of previously unknown biomarkers, which could enable cancer detection earlier. Read More
Computational approach predicts effectiveness of bNAb combinations to treat HIV
July 20, 2022 -- Researchers have developed a computational approach to predict the effectiveness of broadly neutralizing antibodies (bNAbs) combinations to treat HIV based on the genetics of the virus. Read More
Scientists identify what flips switch to activate retron’s toxins to prevent viral spread
July 18, 2022 -- European Molecular Biology Laboratory researchers have identified what flips the switch to activate a retron’s toxins to prevent a viral spread, using genetics, proteomics, and bioinformatics. Read More
Mouse DNA methylation array seeks to accelerate high-sample-throughput studies
July 14, 2022 -- Scientists have developed a mouse DNA methylation array that contains more than 296,000 probes and a murine methylome atlas of 1,239 diverse cell types, strains, ages, and pathologies, giving researchers an in-depth view into the basis of health and disease in this important model organism. Read More
Biochemical pathway leads to inflammation characteristic of autoimmune disease: study
July 14, 2022 -- Researchers from the University of California, San Diego School of Medicine, along with colleagues from other institutions, have described the biochemical pathway that leads to inflammation characteristic of autoimmune diseases, which they contend could lead to new anti-inflammatory therapies. Read More
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter